Evidence map›Paper›PMID 26172831›Full record

ArticlePloS one2015

Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune Response.

Christian Theilacker, Ann-Kristin Diederich, Andreas Otto, Irina G Sava, Dominique Wobser, Yinyin Bao, Katrin Hese, Melanie Broszat, Philipp Henneke, Dörte Becher and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Virulence Profiling of Multidrug-Resistant ClinicalMicrobial drug resistance (Larchmont, N.Y.) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Cinnamaldehyde InhibitsFrontiers in microbiology · 2016
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Christian TheilackerCenter for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany; Center for Infectious Disease and Travel Medicine, University Medical Center Freiburg, Freiburg, Germany.
Ann-Kristin DiederichCenter for Infectious Disease and Travel Medicine, University Medical Center Freiburg, Freiburg, Germany; Division of Pediatric Infectious Diseases, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany; Department of Microbiology, Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany.
Andreas OttoInstitute for Microbiology, Department of Microbial Physiology, Ernst-Moritz-Arndt-University, Greifswald, Germany.
Irina G SavaResearch Center for Nutrition and Food Science, Technical University Munich, Freising, Germany.
Dominique WobserCenter for Infectious Disease and Travel Medicine, University Medical Center Freiburg, Freiburg, Germany.
Yinyin BaoCenter for Infectious Disease and Travel Medicine, University Medical Center Freiburg, Freiburg, Germany.
Katrin HeseCenter for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany.
Melanie BroszatCenter for Infectious Disease and Travel Medicine, University Medical Center Freiburg, Freiburg, Germany.
Philipp HennekeCenter for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany; Center for Paediatrics and Adolescent Medicine, University Medical Center Freiburg, Freiburg, Germany.
Dörte BecherInstitute for Microbiology, Department of Microbial Physiology, Ernst-Moritz-Arndt-University, Greifswald, Germany.
Johannes HuebnerCenter for Infectious Disease and Travel Medicine, University Medical Center Freiburg, Freiburg, Germany; Division of Pediatric Infectious Diseases, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany.
University Medical Center Freiburg · DEUniversität Greifswald · DELeibniz-Institute for Food Systems Biology at the Technical University of Munich · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we investigated the impact of the cell membrane composition of E. faecalis on its recognition by the host immune system. To this end, we employed an E. faecalis deletion mutant (ΔbgsA) that does not synthesize the major cell membrane glycolipid diglycosyl-diacylglycerol (DGlcDAG). Proteomic analysis revealed that 13 of a total of 21 upregulated surface-associated proteins of E. faecalis ΔbgsA were lipoproteins. This led to a total lipoprotein content in the cell membrane of 35.8% in ΔbgsA compared to only 9.4% in wild-type bacteria. Increased lipoprotein content strongly affected the recognition of ΔbgsA by mouse macrophages in vitro with an increased stimulation of TNF-α production by heat-fixed bacteria and secreted antigens. Inactivation of the prolipoprotein diacylglycerol transferase (lgt) in ΔbgsA abrogated TNF-α induction by a ΔbgsA_lgt double mutant indicating that lipoproteins mediate increased activation of mouse macrophages by ΔbgsA. Heat-fixed ΔbgsA bacteria, culture supernatant, or cell membrane lipid extract activated transfected HEK cells in a TLR2-dependent fashion; the same was not true of wild-type bacteria. In mice infected intraperitoneally with a sublethal dose of E. faecalis we observed a 70% greater mortality in mice infected with ΔbgsA compared with wild-type-infected mice. Increased mortality due to ΔbgsA infection was associated with elevated plasma levels of the inflammatory cytokines TNF-α, IL-6 and MIP-2. In summary, our results provide evidence that an E. faecalis mutant lacking its major bilayer forming glycolipid DGlcDAG upregulates lipoprotein expression leading to increased activation of the host innate immune system and virulence in vivo.

Indexed as

AnimalsBacterial ProteinsCell LineCell MembraneChemokine CXCL2Enterococcus faecalisFemaleGlycolipidsHEK293 CellsHost-Pathogen InteractionsHumansImmunity, InnateInterleukin-6LipoproteinsMacrophagesMembrane LipidsBacterial ProteinsChemokine CXCL2diglucosyl diacylglycerolGlycolipidsInterleukin-6LipoproteinsMembrane LipidsMembrane ProteinsToll-Like Receptor 2Tumor Necrosis Factor-alpha

Identifiers

PMID26172831
PMCPMC4501811
OpenAlexW1847117303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.